These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36972230)

  • 1. IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected mice.
    Mittereder LR; Swoboda J; De Pascalis R; Elkins KL
    PLoS One; 2023; 18(3):e0283161. PubMed ID: 36972230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70.
    Elkins KL; Cooper A; Colombini SM; Cowley SC; Kieffer TL
    Infect Immun; 2002 Apr; 70(4):1936-48. PubMed ID: 11895957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-23 p19 knockout mice exhibit minimal defects in responses to primary and secondary infection with Francisella tularensis LVS.
    Kurtz SL; Chou AY; Kubelkova K; Cua DJ; Elkins KL
    PLoS One; 2014; 9(10):e109898. PubMed ID: 25296161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.
    Kurtz SL; Foreman O; Bosio CM; Anver MR; Elkins KL
    Infect Immun; 2013 Feb; 81(2):585-97. PubMed ID: 23230288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
    Zhang P; Katz J; Michalek SM
    Mol Immunol; 2009 Feb; 46(4):677-87. PubMed ID: 18929413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.
    Melillo AA; Foreman O; Bosio CM; Elkins KL
    Infect Immun; 2014 Apr; 82(4):1477-90. PubMed ID: 24421047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Francisella tularensis LVS-induced Interleukin-12 p40 cytokine production mediates dendritic cell migration through IL-12 Receptor β1.
    Slight SR; Lin Y; Messmer M; Khader SA
    Cytokine; 2011 Sep; 55(3):372-9. PubMed ID: 21669537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
    Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW
    Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
    Cowley SC; Meierovics AI; Frelinger JA; Iwakura Y; Elkins KL
    J Immunol; 2010 May; 184(10):5791-801. PubMed ID: 20393138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential requirements by CD4+ and CD8+ T cells for soluble and membrane TNF in control of Francisella tularensis live vaccine strain intramacrophage growth.
    Cowley SC; Sedgwick JD; Elkins KL
    J Immunol; 2007 Dec; 179(11):7709-19. PubMed ID: 18025217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An
    Golovliov I; Lindgren H; Eneslätt K; Conlan W; Mosnier A; Henry T; Sjöstedt A
    Front Cell Infect Microbiol; 2016; 6():152. PubMed ID: 27933275
    [No Abstract]   [Full Text] [Related]  

  • 12. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

  • 13. NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS.
    Elkins KL; Colombini SM; Krieg AM; De Pascalis R
    Microbes Infect; 2009 Jan; 11(1):49-56. PubMed ID: 18992838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
    Jia Q; Bowen R; Sahakian J; Dillon BJ; Horwitz MA
    Infect Immun; 2013 May; 81(5):1550-61. PubMed ID: 23439306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12Rβ2 is critical for survival of primary Francisella tularensis LVS infection.
    Melillo AA; Foreman O; Elkins KL
    J Leukoc Biol; 2013 May; 93(5):657-67. PubMed ID: 23440500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intra-macrophage bacterial replication.
    Collazo CM; Sher A; Meierovics AI; Elkins KL
    Microbes Infect; 2006 Mar; 8(3):779-90. PubMed ID: 16513388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.
    Dreisbach VC; Cowley S; Elkins KL
    Infect Immun; 2000 Apr; 68(4):1988-96. PubMed ID: 10722593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing effects of interleukin-10 on cutaneous and pulmonary Francisella tularensis live vaccine strain infection.
    Metzger DW; Salmon SL; Kirimanjeswara G
    Infect Immun; 2013 Jun; 81(6):2022-7. PubMed ID: 23529615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of secondary lethal systemic Francisella LVS challenge depends largely on interferon gamma.
    Elkins KL; Colombini SM; Meierovics AI; Chu MC; Chou AY; Cowley SC
    Microbes Infect; 2010 Jan; 12(1):28-36. PubMed ID: 19781659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.